Health Alert: FDA Panel Votes to Restrict Avandia

The majority of the panel voted to pull it from the shelves.


The prescription drug Avandia, which is used to treat diabetes, is under fire because of its potential risk for causing heart attacks. An FDA panel voted today to strictly control the distribution of the drug. The 33-member advisory board was sharply divided. Twelve voted to remove the drug from shelves completely, 10 for continued sale but with new label revisions and possible restrictions, seven to add more warnings and three for no change at all. We vote to call your doctor and tread lightly with Avandia.

Read more at the New York Times.

The Root encourages respectful debate and dialogue in our commenting community. To improve the commenting experience for all our readers we will be experimenting with some new formats over the next few weeks. During this transition period the comments section will be unavailable to users.

We apologize for any inconvenience and appreciate your continued support of The Root.

While we are experimenting, please feel free to leave feedback below about your past experiences commenting at The Root.